Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Novel Molecular Pathophysiological Mechanisms of Secondary Brain Injury in Post-cardiac Arrest Syndrome Patients Using Cerebrospinal Fluid Multi-omics Analysis

NCT07481396 is registered in ClinicalTrials.gov with Chungnam National University Hospital as lead sponsor.

NCT NCT07481396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07481396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Novel Molecular Pathophysiological Mechanisms of Secondary Brain Injury in Post-cardiac Arrest Syndrome Patients Using Cerebrospinal Fluid Multi-omics Analysis
Lead sponsor
Chungnam National University Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2025
Completion date
February 28, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest (ca), cerebrospinal fluid, hypoxic-ischemic brain injury, multiomics